Loading provider…
- Featuresarrow_drop_down
- Solutionsarrow_drop_down
Loading provider…
Your Medical Sales Assistants that help you easily find, convert and close your ideal providersHematology & Oncology Physician in Omaha, NE
NPI: 1205816667Primary Practice Location
THE NEBRASKA MEDICAL CENTER
4350 Dewey Ave, Omaha, NE
Primary Employer
Oncology Hematology West, PC
nebraskacancer.com
HQ Phone
Get M.D. Stefano's Phone Numberphone_androidMobile
Get M.D. Stefano's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardNE State Medical License
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99214Established patient office or other outpatient visit, 30-39 minutes | 637 | 1,730 |
| 2 | 85025Complete blood cell count (red cells, white blood cell, platelets), automated test | 547 | 2,550 |
| 3 | 80053Blood test, comprehensive group of blood chemicals | 476 | 1,733 |
| 4 | 99213Established patient office or other outpatient visit, typically 15 minutes | 365 | 524 |
| 5 | 83615Lactate dehydrogenase (enzyme) level | 335 | 809 |
Authors: David Sambol, Surinder Batra, Subhankar Chakraborty, Ralph Hauke
Journal: Case Rep Oncol
Publication Date: 2011-03-12
Immunological effects and therapeutic role of C5a in cancer.
Authors: Ralph Hauke
Publication Date: 2014-11-13
Increased incidence of a second lymphoproliferative malignancy in patients with multiple myeloma--a SEER based study.
Authors: Subhankar Chakraborty, Ralph Hauke
Publication Date: 2012-10-13
Lead Sponsor: National Cancer Institute (NCI)
Intervention / Treatment: PROCEDURE: Bone Marrow Biopsy, DRUG: Venetoclax, PROCEDURE: Positron Emission Tomography, PROCEDURE: Biospecimen Collection, DRUG: Cyclophosphamide, DRUG: Prednisone, DRUG: Etoposide, DRUG: Vincristine Sulfate, BIOLOGICAL: Rituximab, PROCEDURE: Computed Tomography, DRUG: Doxorubicin Hydrochloride, PROCEDURE: Lumbar Puncture
Lead Sponsor: GlaxoSmithKline
Intervention / Treatment: DRUG: Belantamab mafodotin, DRUG: Pom/dex (Pomalidomide plus low dose Dexamethasone)
Lead Sponsor: National Cancer Institute (NCI)
Intervention / Treatment: PROCEDURE: Bone Marrow Biopsy, PROCEDURE: Biospecimen Collection, DRUG: Cytarabine, PROCEDURE: Multigated Acquisition Scan, DRUG: Uproleselan, PROCEDURE: Bone Marrow Aspiration, PROCEDURE: Echocardiography Test, DRUG: Daunorubicin
